Form 4 for BLCO Bausch & Lomb Corp
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0000899243-22-017761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-12 | 2022-05-10 | BLCO | Bausch Health Companies Inc. | 10% | S - Sale | $17.06 | -35.00M | 315.00M | -10% | -$597.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-05-10 | S | D | 35,000,000 | $17.06 | 315,000,000 | I See footnote | — | — | (F1) Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. (F2) Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. |